Today's discussion on unraveling BPC 157 Peptide

This episode is designed for listeners interested in clinical research, peptide science, endocrinology, and translational medicine, offering an evidence-based perspective without speculation or medical advice.Topics include:Tesamorelin peptide mechanism of actionPreclinical and animal studiesPhase II and Phase III clinical trial dataFDA approval and HIV-associated lipodystrophyGrowth hormone, IGF-1, and metabolic effectsSafety, limitations, and ongoing research

In this episode, we deliver an in-depth, evidence-based discussion on the MOTS-c peptide, a mitochondria-derived peptide that has gained significant attention in metabolic health, insulin sensitivity, exercise performance, and longevity research. MOTS-c is unique among peptides because it is encoded by mitochondrial DNA and functions as a key regulator of cellular energy metabolism and stress adaptation.This podcast explores how MOTS-c works at the cellular level, its role in activating AMPK pathways, regulating glucose utilization, and supporting mitochondrial resilience. We examine preclinical and emerging human research on MOTS-c’s potential impact on metabolic syndrome, age-related decline, obesity, inflammation, and exercise capacity, while clearly distinguishing established science from ongoing investigation.

Human Chorionic Gonadotropin (hCG) is one of the most discussed—and misunderstood—peptides in hormone optimization, metabolic health, and weight management. In this in-depth podcast episode, we break down the science of the hCG peptide, exploring its mechanism of action, clinical research, hormonal effects, and proposed fat-loss applications.This episode examines peer-reviewed clinical data, expert peptide commentary, and historical medical use of hCG in endocrinology, fertility medicine, hypogonadism, and metabolic regulation. We also address common myths surrounding hCG injections and hCG diet protocols, separating marketing claims from evidence-based medicine.

This is a blend of bpc157, Tb500 and Ghkcu the copper peptide

Semaglutide vs Tirzepatide and now Retatrutide the possible new standard